Ledger.Open graph →
SEC Form D · filed March 10, 2023

SEngine Precision Medicine, Inc

Offering
$3.6M
Sold
$600K
Exemption
Rule 506(b)
Industry
Biotechnology
Location
SEATTLE, WA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (13)

Carla Grandori · Seattle, WAExec · Director · PromoterElliott Burkland · Seattle, WADirectorChristopher Kemp · Seatttle, WAExec · PromoterTony Hsu · MERCER ISLAND, WAExecDonatien-Xavier Martin · Munsbach, LuxembourgExec · PromoterJerome Misso · Munsbach, LuxembourgDirectorAndrew S. Gazdecki · San Mateo, CAExec · Director · PromoterPablo Prichard · Seattle, WADirectorRavikiran Thummalapenta · CENTERVILLE, VADirectorTom B. Orradre · Newport Beach, CAExec · PromoterGeorge Matelich · Brooklyn, NYExec · Director · PromoterPablo Prichard · Seattle, WADirectorTony Hsu · Los Angeles, CAExec

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗